ClinicalTrials.Veeva

Menu

Investigation of Genetic Disease Marker Associated With Korean Glaucoma Patients

C

Chungnam National University

Status

Completed

Conditions

Single-nucleotide Polymorphism (SNP) for Glaucoma

Treatments

Genetic: SNP analysis of the DNA

Study type

Observational

Funder types

Other

Identifiers

NCT01025024
A080587 (Other Grant/Funding Number)
CNUH81510-886

Details and patient eligibility

About

A single-nucleotide polymorphism (SNP) analysis of DNA obtained from peripheral blood of the glaucoma patients and the normal control will be performed to find genetic marker for primary open angle glaucoma.

Full description

Unrelated Korean subjects who have primary open angle glaucoma were recruited in the current study. Genotyping for various SNP associated with POAG due to the linkage disequilibrium patterns is to be performed. Genotypes would be statistically compared between patients with primary open angle glaucoma and normal control subjects free of any eye diseases.

Enrollment

1,224 patients

Sex

All

Ages

30+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of primary open angle glaucoma

Exclusion criteria

  • Primary open angle glaucoma combined with congenital ocular disease
  • Primary open angel glaucoma combined with other ocular disease
  • Significant systemic disease other than systemic hypertension and diabetes

Trial design

1,224 participants in 2 patient groups

POAG group
Description:
Elevated intraocular pressure normal open angle glaucomatous optic nerve head abnormality glaucomatous visual field defect
Treatment:
Genetic: SNP analysis of the DNA
Normal control
Description:
Normal intraocular pressure No optic disc abnormality No visual field defect No significant ocular and systemic disease
Treatment:
Genetic: SNP analysis of the DNA

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems